But your eyes are telling everyone a completely different story
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability
you are investing in a formulation designed with your biological needs in mind
Yu Q, Katlinskaya YV, Carbone CJ, Zhao B, Katlinski KV, Zheng H et al
GLP-1 is simply a much more powerful signal for beta cells than glucagon